Conference Coverage
-
Conference Coverage
Signals of gut microbiome interaction with experimental Alzheimer’s drug prompt new trial
LOS ANGELES – The first reporting of microbiome data in an Alzheimer’s drug trial opens the door for further investigation of this new endpoint....
-
Conference Coverage
In MS, iron-ringed lesions may add to imaging toolkit
STOCKHOLM – Brain lesions with iron rings were detected only in MRI scans of MS patients.
-
Conference Coverage
Continuation of natalizumab treatment reduces risk of MS relapses during pregnancy
STOCKHOLM – Natalizumab treatment after the first trimester may not be associated with significant fetal risks.
-
Conference Coverage
Cannabis-using MS patients improve cognition with 28 days of abstinence
STOCKHOLM – “It’s good for neurologists to know that, if they prescribe cannabis or their patient is self-medicating and chooses to stop, their...
-
Conference Coverage
Tocilizumab beat azathioprine for NMOSD
STOCKHOLM – The first-ever head-to-head trial compared the two drugs in highly relapsing neuromyelitis optica spectrum disorder.
-
Conference Coverage
Baseline neurofilament light levels track with brain volume loss in MS
STOCKHOLM – Ten-year data strengthen neurofilament light’s potential prognostic role.
-
Conference Coverage
Intensive cognitive training may be needed for memory gains in MS
STOCKHOLM – Patients with MS saw the best results with the most intensive memory strategies.
-
Conference Coverage
Investigators use ARMSS score to predict future MS-related disability
STOCKHOLM – The score is the basis for a measurement that is stable over time.
-
Conference Coverage
MRI saves money, better than CT in acute stroke
ST. LOUIS – The annual savings from skipping CT in favor of MRI for patients with suspected stroke would offset the cost of round-the-clock MRI...
-
Conference Coverage
In patients with CIS, combined omics predicts conversion to clinically definite MS
STOCKHOLM – Oligoclonal band status is helpful for diagnosis, but cannot predict who will go on to develop clinically definite MS.
-
Conference Coverage
In utero Zika exposure can have delayed consequences
Infants born following in utero Zika virus exposure can appear normal at birth but have neurodevelopmental problems later.
-
Conference Coverage
Placebo response in negative rituximab BeatMG trial provides important lessons
AUSTIN, TEX. – The BeatMG trial offers clues and reinforces the need for placebo-controlled studies, Dr. Richard Nowak said.
-
Conference Coverage
Neurologists consider flu shot safe in most patients with autoimmune neuromuscular disorders
AUSTIN, TEX. – Neurologists are circumspect about recommending influenza vaccination for patients with a history of...
-
Conference Coverage
Study examines utility of repeat outpatient electrodiagnostic testing
AUSTIN, TEX. – Repeat testing for the same indication may not change symptom or disease management in about one-third of cases, a preliminary...
-
Conference Coverage
Which patients are most likely to have a positive RNS test for myasthenia gravis?
AUSTIN, TEX. – The diagnostic yield of the test may be highest in patients with MGFA Class III or higher who are...
Latest News
-
From the Journals
Hyperphosphorylated tau visible in TBI survivors decades after brain injury
The study suggests that tau brain imaging can provide valuable information about TBI and might be able to identify patients who could benefit from...
-
From the Journals
Neurostimulation device may treat vertigo in patients with vestibular migraine
In an open-label study, patients used noninvasive vagus nerve stimulation to treat acute vestibular migraine attacks.
-
From the Journals
How does alcohol intake affect dementia risk in older adults?
The association may be more consistently adverse in adults with mild cognitive impairment.
-
Latest News
Concussion effects may linger on MRI 1 year after athletes resume play
More research is needed to understand the optimal recovery time from a neurobiological perspective, a study suggests.
Literature Review
-
Literature Review
Early infusion of mononuclear cells may benefit stroke patients
Well-designed RCTs are needed to further assess safety and efficacy of the approach.
-
Literature Review
Accounting for sex may improve diagnosis of amnestic MCI
The rate of diagnostic error when applying criteria that account for age and education, but not sex, is approximately 20%.
-
Literature Review
Increased Parkinson’s disease risk seen with bipolar disorder
People with bipolar disorder may be at increased risk of developing Parkinson’s disease in later life.
-
Literature Review
Neurologists publish consensus statement on stridor in MSA
The statement provides guidance on the diagnosis, prognosis, and treatment of stridor in patients with MSA, as well as indicating areas for future...
FDA/CDC
-
FDA/CDC
FDA expands Dysport’s upper-limb spasticity indication to children
AbobotulinumtoxinA (Dysport) is now approved for upper-limb spasticity in both children 2 years and older (excluding those with cerebral palsy)...
-
News from the FDA/CDC
FDA approves Reyvow for acute migraine treatment
The approval of lasmiditan (Reyvow) is based on a pair of randomized, double-blind, placebo-controlled trials that included more than 3,000...